Biomedical engineers have invented a new device that more quickly and accurately "listens in" on the chemical messages that tell our cells how to multiply.
The 3DCulturePro system from Bose Corp. is a multi-specimen perfusion bioreactor designed for biologists, biomedical researchers and scientists who require reproducible and reliable tissue growth.
Painful insulin injections could become a thing of the past for the millions of Americans who suffer from diabetes, thanks to a new invention from researchers who have created a “smart insulin patch” that can detect increases in blood sugar levels and secrete doses of insulin into the bloodstream whenever needed.
Scientists have devised a powerful set of chemical methods for exploring the biology of proteins.
Gene previously linked to obesity is unrelated, says new study.
The southern pine beetle, which for generations has attacked forests throughout the southeastern United States, is methodically making its way into the Northeast, destroying thousands of trees in New York, New Jersey and elsewhere.
A new study reveals that extreme exercise could result in blood poisoning, related to the leakage of intestinal bacteria into the blood stream.
A species of large cat not seen in the U.S. in 77 years is now officially extinct, according to the U.S. Fish and Wildlife Service.
For the first time, a study has shown that infants with emerging autism at 15 months, and two years, can earlier—even at nine months—display enhanced visual searching ability.
The BIOSTAT A from Sartorius Stedim Biotech is a compact bioreactor/fermenter designed specifically as an entry-level model for fermentation and cell culture as well as for educational purposes.
Study provides deep insights into course, makeup of deadly disease.
A protein long believed to only guard the nucleus also regulates gene expression and stem cell development.
Researchers discover that a protein called Taranis could hold the key to a good night's sleep.
While the Phase III portion of the pipeline is comparatively small, it is followed by a relatively large Phase II, indicating that there will be a sustained stream of products moving through the later development stages.
To the untrained eye, the graph looked like a very volatile day on Wall Street - jagged peaks and valleys in red, blue and green, displayed on a wall. But the story it told was not about economics. It was a glimpse into the brains of Shaul Yahil and Shaw Bronner, two researchers at a Yale lab, as they had a little chat.